NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $837,697 | -1.8% | 8,224 | -2.7% | 0.13% | -1.5% |
| Q2 2023 | $853,194 | +19.5% | 8,455 | +9.0% | 0.14% | +12.4% |
| Q1 2023 | $713,736 | +1.1% | 7,758 | -0.3% | 0.12% | -4.7% |
| Q4 2022 | $705,983 | +13.3% | 7,782 | -5.0% | 0.13% | +15.5% |
| Q3 2022 | $623,000 | -11.5% | 8,192 | -1.6% | 0.11% | -14.1% |
| Q2 2022 | $704,000 | +110.8% | 8,327 | +119.5% | 0.13% | +103.2% |
| Q1 2022 | $334,000 | -8.7% | 3,793 | -11.2% | 0.06% | -76.6% |
| Q4 2018 | $366,000 | -22.8% | 4,271 | -22.2% | 0.27% | -14.6% |
| Q3 2018 | $474,000 | +12.3% | 5,487 | -1.7% | 0.32% | +1.9% |
| Q2 2018 | $422,000 | +9.0% | 5,581 | +16.6% | 0.31% | -4.6% |
| Q1 2018 | $387,000 | -5.4% | 4,786 | -1.6% | 0.32% | +3.5% |
| Q4 2017 | $409,000 | +2.8% | 4,866 | +4.9% | 0.31% | -10.3% |
| Q3 2017 | $398,000 | +5.9% | 4,640 | +3.0% | 0.35% | -6.4% |
| Q2 2017 | $376,000 | +34.8% | 4,506 | +19.9% | 0.37% | +11.3% |
| Q1 2017 | $279,000 | – | 3,758 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |